[Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004338:Drug Combinations / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007610:Kallikreins / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005343:Fibrinolytic Agents; C035657:Nico-Padutin; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D007610:Kallikreins
Bilanz eines kombinierten Einsatzes von Nico-Padutin forte und Depot-Padutin bei peripherer arterieller Verschlusskrankheit.